Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
Cancer Res
    August 2017
  1. JIN L, Vu T, Yuan G, Datta PK, et al
    STRAP promotes stemness of human colorectal cancer via epigenetic regulation of the NOTCH pathway.
    Cancer Res. 2017 Aug 21. pii: canres.0286.2017.
    >> Share

    June 2017
  2. HOU PC, Li YH, Lin SC, Lin SC, et al
    Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness.
    Cancer Res. 2017 Jun 26. pii: canres.2990.2016.
    >> Share

  3. KONDELIN J, Gylfe AE, Lundgren S, Tanskanen T, et al
    Comprehensive evaluation of protein coding mononucleotide microsatellites in microsatellite-unstable colorectal cancer.
    Cancer Res. 2017 Jun 13. pii: canres.0682.2017.
    >> Share

  4. YOKOYAMA Y, Watanabe T, Tamura Y, Hashizume Y, et al
    Autocrine BMP-4 signaling is a therapeutic target in colorectal cancer.
    Cancer Res. 2017 Jun 13. pii: canres.0112.2017.
    >> Share

    May 2017
  5. KLOOSTERMAN WP, Coebergh van den Braak RRJ, Pieterse M, van Roosmalen MJ, et al
    A systematic analysis of oncogenic gene fusions in primary colon cancer.
    Cancer Res. 2017 May 16. pii: canres.3563.2017.
    >> Share

  6. TOMKOVICH S, Yang Y, Winglee K, Gauthier J, et al
    Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.
    Cancer Res. 2017;77:2620-2632.
    >> Share

  7. LANG M, Berry D, Passecker K, Mesteri I, et al
    HuR Small-Molecule Inhibitor Elicits Differential Effects in Adenomatosis Polyposis and Colorectal Carcinogenesis.
    Cancer Res. 2017;77:2424-2438.
    >> Share

    April 2017
  8. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    >> Share

  9. HUANG B, Yang H, Cheng X, Wang D, et al
    tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 26. pii: canres.3146.2016.
    >> Share

  10. KOTELEVETS L, Chastre E, Caron J, Mougin J, et al
    A squalene-based nanomedicine for oral treatment of colon cancer.
    Cancer Res. 2017 Apr 17. pii: canres.1741.2016.
    >> Share

  11. NIMANONG S, Ostroumov D, Wingerath J, Knocke S, et al
    CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations.
    Cancer Res. 2017;77:1918-1926.
    >> Share

  12. EDUATI F, Doldan-Martelli V, Klinger B, Cokelaer T, et al
    Drug resistance mechanisms in colorectal cancer dissected with cell type-specific dynamic logic models.
    Cancer Res. 2017 Apr 5. pii: canres.0078.2017.
    >> Share

    March 2017
  13. HSIAO KY, Lin YC, Gupta SK, Chang N, et al
    Non-coding effects of circular RNA CCDC66 promote colon cancer growth and metastasis.
    Cancer Res. 2017 Mar 1. pii: canres.1883.2016.
    >> Share

  14. TIE G, Yan J, Khair L, Messina J, et al
    Hypercholesterolemia increases colorectal cancer incidence by reducing production of NKT and gammadelta T cells from hematopoietic stem cells.
    Cancer Res. 2017 Mar 1. pii: canres.1916.2016.
    >> Share

  15. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    >> Share

  16. FANG M, Li Y, Huang K, Qi S, et al
    IL-33 promotes colon cancer cell stemness via JNK activation and macrophage recruitment.
    Cancer Res. 2017 Mar 1. pii: canres.1602.2016.
    >> Share

  17. MAHNE AE, Mauze S, Joyce-Shaikh B, Xia J, et al
    Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Cancer Res. 2017;77:1108-1118.
    >> Share

    February 2017
  18. BLAJ C, Schmidt EM, Lamprecht S, Hermeking H, et al
    Oncogenic effects of high MAPK activity in colorectal cancer mark progenitor cells and persist irrespective of RAS mutations.
    Cancer Res. 2017 Feb 15. pii: canres.2821.2016.
    >> Share

  19. TONG J, Wang P, Tan S, Chen D, et al
    Mcl-1 degradation is required for targeted therapeutics to eradicate colon cancer cells.
    Cancer Res. 2017 Feb 15. pii: canres.3242.2016.
    >> Share

    January 2017
  20. ROKAVEC M, Hermeking H
    Cellular model of colon cancer progression reveals signatures of mRNAs, miRNA, lncRNAs and epigenetic modifications associated with metastasis.
    Cancer Res. 2017 Jan 27. pii: canres.3236.2016.
    >> Share

  21. MATHOT L, Kundu S, Ljungstrom V, Svedlund J, et al
    Somatic ephrin receptor mutations are associated with metastasis in primary colorectal cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1921.2016.
    >> Share

  22. REYNAUD C, Ferreras L, Di Mauro P, Kan C, et al
    Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone.
    Cancer Res. 2017;77:268-278.
    >> Share

  23. VIENNOIS E, Merlin D, Gewirtz AT, Chassaing B, et al
    Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.
    Cancer Res. 2017;77:27-40.
    >> Share

  24. KANG DW, Lee SW, Hwang WC, Lee BH, et al
    Phospholipase D1 Acts through Akt/TopBP1 and RB1 to Regulate the E2F1-Dependent Apoptotic Program in Cancer Cells.
    Cancer Res. 2017;77:142-152.
    >> Share

  25. TIAN X, Nguyen M, Foote HP, Caster JM, et al
    CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1alpha.
    Cancer Res. 2017;77:112-122.
    >> Share

    November 2016
  26. CEJAS P, Cavazza A, Yandava C, Moreno V, et al
    Transcriptional regulator CNOT3 defines an aggressive colorectal cancer subtype.
    Cancer Res. 2016 Nov 29. pii: canres.1346.2016.
    >> Share

  27. USHIJIMA T, Yoshino T
    The Moment that KRAS Mutation Started to Evolve into Precision Medicine in Metastatic Colorectal Cancer.
    Cancer Res. 2016;76:6443-6444.
    >> Share

    October 2016
  28. ZHANG M, Xu C, Wen L, Han MK, et al
    A hyaluronidase responsive nanoparticle-based drug delivery system for targeting colon cancer cells.
    Cancer Res. 2016 Oct 14. pii: canres.1681.2016.
    >> Share

  29. ESSIEN BE, Sundaresan S, Ocadiz-Ruiz R, Chavis A, et al
    Transcription factor ZBP-89 drives a feedforward loop of beta-catenin expression in colorectal cancer.
    Cancer Res. 2016 Oct 10. pii: canres.3150.2015.
    >> Share

    September 2016
  30. HORN T, Ferretti S, Ebel N, Tam A, et al
    High order drug combinations are required to effectively kill colorectal cancer cells.
    Cancer Res. 2016 Sep 22. pii: canres.3425.2015.
    >> Share

    August 2016
  31. DI CECILIA S, Zhang F, Sancho-Medina A, Li S, et al
    RBM-AS1 is critical for self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 Aug 12. pii: canres.1824.2015.
    >> Share

  32. LIMAGNE E, Euvrard R, Thibaudin M, Rebe C, et al
    Accumulation of MDSC and Th17 cells in patients with metastatic colorectal cancer predict the efficacy of a FOLFOX-bevacizumab drug treatment regimen.
    Cancer Res. 2016 Aug 5. pii: canres.3164.2015.
    >> Share

    Commentary on "KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer".
    Cancer Res. 2016;76:4309-10.
    >> Share

    July 2016
    Colon Cancer Germline Genetics: The Unbelievable Year 1993 and Thereafter.
    Cancer Res. 2016;76:4025-7.
    >> Share

    June 2016
  35. SU L, Luo Y, Yang Z, Yang J, et al
    MEF2D transduces microenvironment stimuli to ZEB1 to promote epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Cancer Res. 2016 Jun 30. pii: canres.0246.2016.
    >> Share

  36. KUO WT, Lee TC, Yu LC
    Eritoran suppresses colon cancer by altering a functional balance in Toll-like receptors that bind lipopolysaccharide.
    Cancer Res. 2016 Jun 21. pii: canres.0172.2016.
    >> Share

  37. ODDO D, Sennott EM, Barault L, Valtorta E, et al
    Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer.
    Cancer Res. 2016 Jun 16. pii: canres.0396.2016.
    >> Share

    May 2016
  38. ALEKSANDROVA K, Giuseppe RD, Isermann B, Biemann R, et al
    Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC - Potsdam Cohort Study.
    Cancer Res. 2016 May 23. pii: canres.3464.2015.
    >> Share

  39. ZHOU J, Wang H, Zhang H, Lutz AM, et al
    VEGFR2-targeted three-dimensional ultrasound imaging can predict responses to anti-angiogenic therapy in preclinical models of colon cancer.
    Cancer Res. 2016 May 20. pii: canres.3271.2015.
    >> Share

  40. GIRAUD J, Failla LM, Pascussi JM, Lagerqvist EL, et al
    Autocrine secretion of progastrin promotes the survival and self-renewal of colon cancer stem-like cells.
    Cancer Res. 2016 May 4. pii: canres.1497.2015.
    >> Share

    April 2016
  41. FEHRINGER G, Kraft P, Pharoah PD, Eeles RA, et al
    Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations.
    Cancer Res. 2016 Apr 20. pii: canres.2980.2015.
    >> Share

  42. HOUSSEAU F, Wu S, Wick EC, Fan H, et al
    Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis.
    Cancer Res. 2016;76:2115-24.
    >> Share

  43. SRINIVASAN T, Walters J, Bu P, Than EB, et al
    NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer Initiating Cells.
    Cancer Res. 2016 Apr 11. pii: canres.3198.2015.
    >> Share

    March 2016
  44. RAYNAL NJ, Lee JT, Wang Y, Beaudry A, et al
    Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer.
    Cancer Res. 2016;76:1494-505.
    >> Share

    February 2016
  45. RAO CV, Sanghera S, Zhang Y, Biddick L, et al
    Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.
    Cancer Res. 2016;76:630-42.
    >> Share

  46. MARUSIAK AA, Stephenson NL, Baik H, Trotter EW, et al
    Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.
    Cancer Res. 2016;76:724-35.
    >> Share

    January 2016
  47. XING C, Lu XX, Guo PD, Shen T, et al
    Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis.
    Cancer Res. 2016;76:83-95.
    >> Share

  48. TAVARE R, Escuin-Ordinas H, Mok S, McCracken MN, et al
    An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy.
    Cancer Res. 2016;76:73-82.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016